Rishi J. Khusial
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma
Khusial, Rishi J.; Honkoop, Persijn J.; Usmani, Omar; Soares, Marcia; Simpson, Andrew; Biddiscombe, Martyn; Meah, Sally; Bonini, Matteo; Lalas, Antonios; Polychronidou, Eleftheria; Koopmans, Julia G.; Moustakas, Kostas; Snoeck-Stroband, Jiska B.; Ortmann, Steffen; Votis, Konstantinos; Tzovaras, Dimitrios; Chung, Kian Fan; Fowler, Stephen; Sont, Jacob K.
Authors
Persijn J. Honkoop
Omar Usmani
Marcia Soares
Dr Andrew Simpson A.Simpson2@hull.ac.uk
Lecturer
Martyn Biddiscombe
Sally Meah
Matteo Bonini
Antonios Lalas
Eleftheria Polychronidou
Julia G. Koopmans
Kostas Moustakas
Jiska B. Snoeck-Stroband
Steffen Ortmann
Konstantinos Votis
Dimitrios Tzovaras
Kian Fan Chung
Stephen Fowler
Jacob K. Sont
Abstract
Background: Self-management programs have beneficial effects on asthma control, but their implementation in clinical practice is poor. Mobile health (mHealth) could play an important role in enhancing self-management. Objective: To assess the clinical effectiveness and technology acceptance of myAirCoach-supported self-management on top of usual care in patients with asthma using inhalation medication. Methods: Patients were recruited in 2 separate studies. The myAirCoach system consisted of an inhaler adapter, an indoor air-quality monitor, a physical activity tracker, a portable spirometer, a fraction exhaled nitric oxide device, and an app. The primary outcome was asthma control; secondary outcomes were exacerbations, quality of life, and technology acceptance. In study 1, 30 participants were randomized to either usual care or myAirCoach support for 3 to 6 months; in study 2, 12 participants were provided with the myAirCoach system in a 3-month before-after study. Results: In study 1, asthma control improved in the intervention group compared with controls (Asthma Control Questionnaire difference, 0.70; P = .006). A total of 6 exacerbations occurred in the intervention group compared with 12 in the control group (hazard ratio, 0.31; P = .06). Asthma-related quality of life improved (mini Asthma-related Quality of Life Questionnaire difference, 0.53; P = .04), but forced expiratory volume in 1 second was unchanged. In study 2, asthma control improved by 0.86 compared with baseline (P = .007) and quality of life by 0.16 (P = .64). Participants reported positive attitudes toward the system. Discussion: Using the myAirCoach support system improves asthma control and quality of life, with a reduction in severe asthma exacerbations. Well-validated mHealth technologies should therefore be further studied.
Citation
Khusial, R. J., Honkoop, P. J., Usmani, O., Soares, M., Simpson, A., Biddiscombe, M., Meah, S., Bonini, M., Lalas, A., Polychronidou, E., Koopmans, J. G., Moustakas, K., Snoeck-Stroband, J. B., Ortmann, S., Votis, K., Tzovaras, D., Chung, K. F., Fowler, S., & Sont, J. K. (2020). Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma. The journal of allergy and clinical immunology. In practice, 8(6), 1972-1979.e8. https://doi.org/10.1016/j.jaip.2020.02.018
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 10, 2020 |
Online Publication Date | Mar 3, 2020 |
Publication Date | 2020-06 |
Deposit Date | Mar 4, 2020 |
Publicly Available Date | Mar 16, 2020 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Print ISSN | 2213-2198 |
Peer Reviewed | Peer Reviewed |
Volume | 8 |
Issue | 6 |
Pages | 1972-1979.e8 |
DOI | https://doi.org/10.1016/j.jaip.2020.02.018 |
Keywords | Immunology and Allergy; asthma; mHealth; app; eHealth; telemedicine; self-management; quality of life; personalized care |
Public URL | https://hull-repository.worktribe.com/output/3456596 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2213219820301781?via%3Dihub |
Files
Published article
(3.2 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
©2020. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
Pre-proof
(1.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
© 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
You might also like
Academic survival: student retention in sport and exercise sciences
(2024)
Journal Article
Short-term heat acclimation protocols for an aging population: Systematic review
(2023)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search